Cosmetic cross-reference

Cetalkonium Chloride

CAS 122-18-9

Cetalkonium Chloride (CAS 122-18-9) is a Phase 2 pharmaceutical compound with 5 bioactivity targets and 28 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

5

SOURCE DrugCentral

Adverse signals

28

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Cetalkonium Chloride

CAS Number

122-18-9

UNII

85474O1N9D

InChIKey

SXPWTBGAZSPLHA-UHFFFAOYSA-M

ChEMBL ID

CHEMBL1644450

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL1644450 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 5 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	MIC	36325 nM	8	-
-	IC50	8933.328571428572 nM	7	-
-	MIC	12.5 ug.mL-1	6	-
-	Potency	13962.480000000001 nM	5	-
-	AC50	31273.566666666666 nM	3	-

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
CETALKONIUM CHLORIDE	47907	SU	MTHSPL
cetalkonium chloride	47907	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Cetalkonium Chloride used for in pharmaceutical contexts?

Cetalkonium Chloride (CAS 122-18-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Cetalkonium Chloride?

Cetalkonium Chloride has 28 DrugCentral/FAERS adverse event associations. Rendered reaction terms include C-reactive protein increased, COVID-19, Condition aggravated, Diarrhoea, Dyspnoea. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Cetalkonium Chloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Cetalkonium Chloride with EU status "restricted".

What clinical phase is Cetalkonium Chloride in?

Cetalkonium Chloride is rendered with ChEMBL max phase 2.